Physician profile
Robert S Epstein
NPI 1124010624
$2,039.81
in general payments reported to CMS, 2019-2025
18 companies · $283 in 2025
The $283 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $207 · 2021: $491 · 2022: $284 · 2023: $258 · 2024: $319 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $838 · Education: $22.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $838.12 |
| Education | $22.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $712.56 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $273.55 | 2019-2024 | Xifaxan |
| Pfizer INC. | $213.72 | 2021-2025 | |
| Madrigal Pharmaceuticals | $176.95 | 2024-2025 | Rezdiffra, Resmetirom |
| Janssen Biotech, INC. | $122.77 | 2022-2024 | Simponi Aria, Simponi, Stelara |
| Intuitive Surgical, INC. | $100.02 | 2022 | |
| Gilead Sciences, INC. | $78.00 | 2021-2022 | |
| Redhill Biopharma INC. | $62.68 | 2020-2021 | |
| Qol Medical, LLC | $52.32 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $49.15 | 2023-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $36.30 | 2019-2024 | Entyvio |
| Ardelyx, INC. | $32.89 | 2025 | Ibsrela |
| Mauna Kea Technologies, INC. | $25.05 | 2024 | |
| Allergan, INC. | $24.69 | 2019 | |
| Phathom Pharmaceuticals, INC. | $23.34 | 2024 | Voquezna |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $20.13 | 2019 | |
| Merck Sharp & Dohme LLC | $19.37 | 2021 | |
| Nestle Healthcare Nutrition INC. | $16.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Epstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.